GATX CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GATX CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.74B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.59B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.41B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.27B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $1.26B | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $304.90M | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $304.40M | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $300.50M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $299.40M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $300.50M | Feb 18, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $333.30M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $284.20M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $259.20M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $155.90M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $143.10M | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $17.80M | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $47.90M | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $39.30M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $46.30M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $56.60M | Feb 18, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $252.60M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $236.30M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $212.70M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $195.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $198.30M | Feb 16, 2024 |
| FY2021 | Dec 31, 2020 | $172.00M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $180.40M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $182.50M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $180.00M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $169.00M | Feb 25, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $648.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $602.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $520.40M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $533.50M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $507.20M | Feb 16, 2024 |
| FY2021 | Dec 31, 2020 | $436.80M | Feb 17, 2022 |
| FY2021 | Dec 31, 2019 | $425.80M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $485.20M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $496.80M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $629.40M | Feb 25, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.67B | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | $1.26B | Feb 16, 2024 |
| FY2023 | Dec 31, 2021 | $1.13B | Feb 16, 2024 |
| FY2021 | Dec 31, 2020 | $860.80M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $722.80M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $913.50M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $566.80M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $595.70M | Feb 25, 2019 |
| FY2017 | Dec 31, 2015 | $681.40M | Feb 21, 2018 |
| FY2016 | Dec 31, 2014 | $1.02B | Feb 22, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.00B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $12.30B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $11.33B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $10.07B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $9.54B | Feb 16, 2024 |
| FY2021 | Dec 31, 2020 | $8.94B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $7.99B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $7.32B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $7.42B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $7.11B | Feb 25, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.36B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $9.86B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $9.05B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $8.04B | Feb 16, 2024 |
| FY2021 | Dec 31, 2021 | $7.52B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $6.98B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $6.45B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $5.83B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $5.63B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $5.76B | Feb 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.75B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.44B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.27B | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $2.03B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $2.02B | Feb 16, 2024 |
| FY2021 | Dec 31, 2020 | $1.96B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $1.84B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $1.79B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $1.79B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $1.35B | Feb 25, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $126.30M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $114.10M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $120.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $117.20M | Feb 16, 2024 |
| FY2021 | Dec 31, 2021 | $123.00M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $143.70M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $81.50M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $82.90M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $85.60M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $78.00M | Feb 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.45B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.21B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $3.01B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $2.83B | Feb 16, 2024 |
| FY2021 | Dec 31, 2021 | $2.75B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $2.68B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $2.60B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $2.42B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $2.26B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $1.83B | Feb 21, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $743.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $401.60M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $450.70M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $303.70M | Feb 16, 2024 |
| FY2021 | Dec 31, 2021 | $344.30M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $292.20M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $151.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $100.20M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $296.50M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $307.50M | Feb 21, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.51B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $8.27B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $7.45B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $6.49B | Feb 16, 2024 |
| FY2021 | Dec 31, 2021 | $5.93B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $5.36B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $4.81B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $4.47B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $4.41B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $4.29B | Feb 21, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 18, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 18, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 35.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 35.58M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 35.46M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 35.27M | Feb 16, 2024 |
| FY2021 | Dec 31, 2021 | 35.42M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | 35.05M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | 34.83M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 36.61M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | 37.90M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | 39.44M | Feb 21, 2018 |